Last update 27 Sep 2025

NRT6008

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
NRT 6008, NRT-6008, NRT6008
Target-
Action-
Mechanism-
Therapeutic Areas
NeoplasmsDigestive System DisordersEndocrinology and Metabolic Disease
Active Indication
Pancreatic adenocarcinomaPancreatic carcinoma non-resectable
Inactive Indication-
Originator Organization
Chengdu New Radiomedicine Technology Co.,Ltd.Chengdu New Radiomedicine Technology Co.,Ltd.
Active Organization
Chengdu New Radiomedicine Technology Co.,Ltd.Chengdu New Radiomedicine Technology Co.,Ltd.
Chongqing Huapont Pharmaceutical Co. Ltd.Chongqing Huapont Pharmaceutical Co. Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with NRT6008
NCT06278454
/ RecruitingPhase 1
A Phase I Study to Evaluate the Safety, Tolerance and Efficacy of NRT6008 Injection in Unresectable Locally Advanced Pancreatic Cancer (LAPC)
100 Clinical Results associated with NRT6008
Login to view more data
100 Translational Medicine associated with NRT6008
Login to view more data
100 Patents (Medical) associated with NRT6008
Login to view more data
100 Deals associated with NRT6008
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Pancreatic adenocarcinomaPhase 1
China
Chongqing Huapont Pharmaceutical Co. Ltd.Chongqing Huapont Pharmaceutical Co. Ltd.
26 Sep 2024
Pancreatic adenocarcinomaPhase 1
China
Chengdu New Radiomedicine Technology Co.,Ltd.Chengdu New Radiomedicine Technology Co.,Ltd.
26 Sep 2024
Pancreatic carcinoma non-resectablePhase 1
China
Chengdu New Radiomedicine Technology Co.,Ltd.Chengdu New Radiomedicine Technology Co.,Ltd.
09 Jan 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free